Dr. Farah Kimura

Thoracic medical oncologist · Memorial Sloan Kettering · United States (US) · Oncology

Tier 3STK-0036GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC, NSCLC
Scientific interests: PD-L1 biomarkers
Engagement preference: Virtual
Advisory boards: 0
Publications: 10
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 28 Jul 2026 (49 days ago)
Next planned contact: 28 Jul 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
28 Jul 2026	Scientific exchange	Virtual	James Whitfield	Vantrexa	Chemotherapy-free first line	0	—	Reviewed	ENG-0064
05 Jan 2026	Advisory board	Phone	James Whitfield	Vantrexa	Sequencing after progressionDuration of response+1	0	—	Reviewed	ENG-0076

Timeline

28 Jul 2026
Scientific exchange
Chemotherapy-free first line
05 Jan 2026
Advisory board
Sequencing after progression, Duration of response, Comparator checkpoint monotherapy

Related stakeholders (6)

Memorial Sloan Kettering

Dr. Oscar Yamamoto
Oncology pharmacist
Tier 3
Dr. Zoë Eriksen
Thoracic medical oncologist
Tier 1
Dr. Andrea Abbott
Thoracic medical oncologist
Tier 1
Dr. Zoë Garcia
Academic nephrologist
Tier 1
Dr. Benedikt Dubois
Headache specialist
Tier 3
Dr. Sven Fischer
Allergist
Tier 3